Skip to main content
. 2017 May 7;2017:7212713. doi: 10.1155/2017/7212713

Figure 2.

Figure 2

Cancer pain: secondary analyses. % change from baseline average pain (Q5 BPI) Cumulative Proportion of Responders Analyses (ITT) at late postinjection period.